These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4785855)

  • 1. [Similarities and variations of behavior of Fasciola hepatica and Schistosoma mansoni during the primo-invasion of the definitive host].
    Buttner A; Lavarde V; Beauvais B; N'Gore-Traore F
    Ann Parasitol Hum Comp; 1973; 48(2):289-300. PubMed ID: 4785855
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of pre-exposure to Fasciola hepatica or Schistosoma mansoni on challenge infection with Fasciola hepatica.
    el-Azazy OM; Schillhorn Van Veen TW
    Vet Parasitol; 1985 Jan; 17(2):173-6. PubMed ID: 3992871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The histopathology of Fasciola hepatica infections in sheep.
    Dow C; Ross JG; Todd JR
    Parasitology; 1968 Feb; 58(1):129-35. PubMed ID: 5689385
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification and localization of a schistosome-associated fucosyllactose determinant expressed by Fasciola hepatica.
    Abdul-Salam F; Mansour MH
    Comp Immunol Microbiol Infect Dis; 2000 Mar; 23(2):99-111. PubMed ID: 10670699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Permanent feeding sites of adult Fasciola hepatica in rabbits?
    Sukhdeo MV; Sangster NC; Mettrick DF
    Int J Parasitol; 1988 Jun; 18(4):509-12. PubMed ID: 3417378
    [No Abstract]   [Full Text] [Related]  

  • 6. On the ultrastructure of epithelial cells in bile ducts of cattle chronically infected with fasciola hepatica.
    Rahko T
    Acta Vet Scand; 1973; 14(2):233-44. PubMed ID: 4728104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of purified antigens in haemagglutination test (IHA) for determination of cross reactivities in diagnosis of fascioliasis and schistosomiasis.
    Azab M el-S ; el Zayat EA
    J Egypt Soc Parasitol; 1996 Dec; 26(3):677-85. PubMed ID: 8918041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The experimental transfer of adult Fasciola hepatica between various mammalian hosts.
    Hughes DL; Harness E
    Res Vet Sci; 1972 Sep; 13(5):422-6. PubMed ID: 4635113
    [No Abstract]   [Full Text] [Related]  

  • 9. Resistance to Fasciola hepatica in calves harbouring primary patent Schistosoma bovis infections.
    Sirag SB; Christensen NO; Nansen P; Monrad J; Frandsen F
    J Helminthol; 1981 Mar; 55(1):63-70. PubMed ID: 7229334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of excretory-secretory circulating antigens in sheep infected with Fasciola hepatica and with Schistosoma mansoni and F. hepatica.
    Rodríguez-Pérez J; Hillyer GV
    Vet Parasitol; 1995 Jan; 56(1-3):57-66. PubMed ID: 7632228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schistosoma mansoni and Fasciola hepatica: cross-resistance in mice.
    Christensen NO; Nansen P; Frandsen F; Bjørneboe A; Monrad J
    Exp Parasitol; 1978 Nov; 46(1):113-20. PubMed ID: 729688
    [No Abstract]   [Full Text] [Related]  

  • 12. An Abies procera-derived tetracyclic triterpene containing a steroid-like nucleus core and a lactone side chain attenuates in vitro survival of both Fasciola hepatica and Schistosoma mansoni.
    Whiteland HL; Chakroborty A; Forde-Thomas JE; Crusco A; Cookson A; Hollinshead J; Fenn CA; Bartholomew B; Holdsworth PA; Fisher M; Nash RJ; Hoffmann KF
    Int J Parasitol Drugs Drug Resist; 2018 Dec; 8(3):465-474. PubMed ID: 30399512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The course of experimental Fasciola hepatica infection in calves with a deficient cellular immunity.
    Flagstad T; Andersen S; Nielsen K
    Res Vet Sci; 1972 Sep; 13(5):468-75. PubMed ID: 4628925
    [No Abstract]   [Full Text] [Related]  

  • 14. Fasciola hepatica: collagen deposition and other histopathology in the rat host's bile duct caused by the parasite and by proline infusion.
    Modavi S; Isseroff H
    Exp Parasitol; 1984 Dec; 58(3):239-44. PubMed ID: 6499998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody responses in murine schistosomiasis and fascioliasis.
    Hillyer GV; Sagramoso de Ateca L
    Am J Trop Med Hyg; 1980 Jul; 29(4):598-601. PubMed ID: 6773428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The complement-fixation test in bilharziasis. I. The value of different extracts of Schistosoma mansoni and Fasciola hepatica worms as antigens.
    ELIAKIM M; DAVIES AM
    Parasitology; 1954 Nov; 44(3-4):407-13. PubMed ID: 13214915
    [No Abstract]   [Full Text] [Related]  

  • 17. Fasciola hepatica: azetidine inhibition of bile duct hyperplasia in the infected rat.
    Girotra KL; Isseroff H
    Exp Parasitol; 1980 Feb; 49(1):41-6. PubMed ID: 7350002
    [No Abstract]   [Full Text] [Related]  

  • 18. Controversial aspects of the life cycle of Fasciola hepatica.
    Moazeni M; Ahmadi A
    Exp Parasitol; 2016 Oct; 169():81-9. PubMed ID: 27475124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of immunity in mice to Fasciola hepatica with a Fasciola/Schistosoma cross-reactive defined immunity antigen.
    Hillyer GV
    Am J Trop Med Hyg; 1985 Nov; 34(6):1127-31. PubMed ID: 3834796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Schistosoma mansoni infections on challenge infections with Fasciola hepatica in mice.
    Hillyer GV
    J Parasitol; 1981 Oct; 67(5):731-3. PubMed ID: 7299588
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.